Literature DB >> 16781787

Expression of growth hormone-releasing hormone (GHRH) and splice variant of GHRH receptors in normal mouse tissues.

C Christodoulou1, A V Schally, I Chatzistamou, A Kondi-Pafiti, K Lamnissou, S Kouloheri, A Kalofoutis, H Kiaris.   

Abstract

Growth hormone-releasing hormone (GHRH) stimulates the production and release of growth hormone in the pituitary and induces cell proliferation in a variety of peripheral tissues and tumors. These extrapituitary effects of GHRH are in many cases mediated by a splice variant of GHRH receptor designated SV1 that differs from the pituitary GHRH receptor in a small portion of its amino-terminal region. While SV1 has been detected in several primary tumors and many cancer cell lines its expression in normal tissues remains unclear. In this study we report the results of an immunohistochemical analysis for SV1 and GHRH expression in normal mouse tissues. For the detection of SV1 immunoreactivity we used a polyclonal antiserum against segments 1-25 of the SV1 receptor protein. Mouse heart, colon, lungs, small intestine, stomach and kidneys exhibited increased SV1 immunoreactivity. These tissues were also positive for GHRH expression, however, tissues such as the endometrium were positive only for GHRH and not for SV1 expression. On the contrary, testis were positive for SV1 and not for GHRH expression. These results indicate that SV1 may play a role in normal physiology.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16781787     DOI: 10.1016/j.regpep.2006.05.001

Source DB:  PubMed          Journal:  Regul Pept        ISSN: 0167-0115


  16 in total

1.  Growth hormone-releasing hormone is produced by adipocytes and regulates lipolysis through growth hormone receptor.

Authors:  F Rodríguez-Pacheco; C Gutierrez-Repiso; S García-Serrano; A Ho-Plagaro; J M Gómez-Zumaquero; S Valdes; M Gonzalo; J Rivas-Becerra; C Montiel-Casado; G Rojo-Martínez; E García-Escobar; E García-Fuentes
Journal:  Int J Obes (Lond)       Date:  2017-06-19       Impact factor: 5.095

2.  Agonists of growth hormone-releasing hormone stimulate self-renewal of cardiac stem cells and promote their survival.

Authors:  Victoria Florea; Sonia S Majid; Rosemeire M Kanashiro-Takeuchi; Ren-Zhi Cai; Norman L Block; Andrew V Schally; Joshua M Hare; Claudia O Rodrigues
Journal:  Proc Natl Acad Sci U S A       Date:  2014-11-17       Impact factor: 11.205

3.  Stimulation of proliferation of MCF-7 breast cancer cells by a transfected splice variant of growth hormone-releasing hormone receptor.

Authors:  Nektarios Barabutis; Erasmia Tsellou; Andrew V Schally; Stavroula Kouloheri; Anastasios Kalofoutis; Hippokratis Kiaris
Journal:  Proc Natl Acad Sci U S A       Date:  2007-03-19       Impact factor: 11.205

4.  Profound Actions of an Agonist of Growth Hormone-Releasing Hormone on Angiogenic Therapy by Mesenchymal Stem Cells.

Authors:  Qunchao Ma; Xiangyang Xia; Quanwei Tao; Kai Lu; Jian Shen; Qiyuan Xu; Xinyang Hu; Yaoliang Tang; Norman L Block; Keith A Webster; Andrew V Schally; Jian'an Wang; Hong Yu
Journal:  Arterioscler Thromb Vasc Biol       Date:  2016-02-11       Impact factor: 8.311

5.  The immunohistochemical expression of growth hormone-releasing hormone receptor splice variant 1 is a favorable prognostic marker in colorectal cancer.

Authors:  Elena Theophanous; Constantina Petraki; Andreas Scorilas; Vassilios Komborozos; George Veloudis; Jozsef L Varga; Marta Zarandi; Andrew V Schally; Michael Koutsilieris
Journal:  Mol Med       Date:  2009-04-15       Impact factor: 6.354

6.  Serum ghrelin levels in growth hormone-sufficient and growth hormone-deficient patients during growth hormone-releasing hormone plus arginine test.

Authors:  B Tarantini; C Ciuoli; S Checchi; A Montanaro; V Bonato; A Theodoropoulou; L Pasqui; F Pacini
Journal:  J Endocrinol Invest       Date:  2009-04       Impact factor: 4.256

7.  Role of growth hormone-releasing hormone in dyslipidemia associated with experimental type 1 diabetes.

Authors:  Maritza J Romero; Rudolf Lucas; Huijuan Dou; Supriya Sridhar; Istvan Czikora; Eby M Mosieri; Ferenc G Rick; Norman L Block; Subbaramiah Sridhar; David Fulton; Neal L Weintraub; Zsolt Bagi; Andrew V Schally
Journal:  Proc Natl Acad Sci U S A       Date:  2016-02-01       Impact factor: 11.205

8.  Ghrelin Receptor Deficiency does not Affect Diet-Induced Atherosclerosis in Low-Density Lipoprotein Receptor-Null Mice.

Authors:  Kirk M Habegger; Erin Grant; Paul Thomas Pfluger; Diego Perez-Tilve; Alan Daugherty; Dennis Bruemmer; Matthias H Tschöp; Susanna M Hofmann
Journal:  Front Endocrinol (Lausanne)       Date:  2011-11-02       Impact factor: 5.555

9.  Knocking down gene expression for growth hormone-releasing hormone inhibits proliferation of human cancer cell lines.

Authors:  N Barabutis; A V Schally
Journal:  Br J Cancer       Date:  2008-05-27       Impact factor: 7.640

10.  Comparison of expression of growth hormone-releasing hormone and its receptor splice variant 1 in different stages of endometriosis.

Authors:  Qiming Wang; Yueyue Wang; Xianhu Fu; Yong Huang
Journal:  Int J Fertil Steril       Date:  2013-03-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.